Corvus Pharmaceuticals
CRVS
CRVS
37 hedge funds and large institutions have $113M invested in Corvus Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7.23% less ownership
Funds ownership: 77.89% → 70.66% (-7.2%)
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Holders
37
Holding in Top 10
3
Calls
$16K
Puts
–
Top Buyers
| 1 | +$4.01M | |
| 2 | +$727K | |
| 3 | +$431K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$369K |
| 5 |
Renaissance Technologies
New York
|
+$296K |
Top Sellers
| 1 | -$7.72M | |
| 2 | -$5.17M | |
| 3 | -$1.36M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.28M |
| 5 |
Millennium Management
New York
|
-$829K |